Log in to access your PharmaMiles
and download the data
| Last Updated on PharmaCompass | Virtual Booth | Country | Holder | DMF No. | Subject | Submission Date | Status | Type | GDUFA DMF Review | GDUFA Review Date | GDUFA Payment Date |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 28/06/2025 | Fresenius Kabi Oncology Limited |
India |
FRESENIUS KABI ONCOLOGY LTD | 33869 | ALECTINIB HYDROCHLORIDE | 2019-06-12 | Inactive | II | N/A | ||
| 28/06/2025 | Hetero Drugs |
India |
HETERO LABS LTD | 39383 | ALECTINIB HYDROCHLORIDE | 2024-01-30 | Active | II | N/A |
